BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16958061)

  • 21. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
    Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
    Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimum apparent diffusion coefficients in the evaluation of brain tumors.
    Kitis O; Altay H; Calli C; Yunten N; Akalin T; Yurtseven T
    Eur J Radiol; 2005 Sep; 55(3):393-400. PubMed ID: 16129247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of perfusion weighted image of CNS lymphoma.
    Lee IH; Kim ST; Kim HJ; Kim KH; Jeon P; Byun HS
    Eur J Radiol; 2010 Oct; 76(1):48-51. PubMed ID: 19500931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic perfusion MRI characteristics of dural metastases and meningiomas: a pilot study characterizing the first-pass wash-in phase beyond relative cerebral blood volume.
    Lui YW; Malhotra A; Farinhas JM; Dasari SB; Weidenheim K; Freeman K; LaSala PA
    AJR Am J Roentgenol; 2011 Apr; 196(4):886-90. PubMed ID: 21427341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibilities of the use of MR tomography-based cerebral blood volume maps in the diagnosis of brain tumors].
    Hackländer T; Hofer M; Reichenbach J; Bettag JM; Kiwit JC; Herzog H; Mödder U
    Rofo; 1995 Dec; 163(6):484-9. PubMed ID: 8547618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
    Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.
    Erdogan C; Hakyemez B; Yildirim N; Parlak M
    J Comput Assist Tomogr; 2005; 29(5):663-7. PubMed ID: 16163039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
    Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
    J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
    Oh J; Cha S; Aiken AH; Han ET; Crane JC; Stainsby JA; Wright GA; Dillon WP; Nelson SJ
    J Magn Reson Imaging; 2005 Jun; 21(6):701-8. PubMed ID: 15906339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the histopathological grade of cerebral gliomas using high b value MR DW imaging at 3-tesla.
    Alvarez-Linera J; Benito-León J; Escribano J; Rey G
    J Neuroimaging; 2008 Jul; 18(3):276-81. PubMed ID: 18482368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors.
    Cho SK; Na DG; Ryoo JW; Roh HG; Moon CH; Byun HS; Kim JH
    Korean J Radiol; 2002; 3(3):171-9. PubMed ID: 12271162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.
    Aronen HJ; Glass J; Pardo FS; Belliveau JW; Gruber ML; Buchbinder BR; Gazit IE; Linggood RM; Fischman AJ; Rosen BR
    Acta Radiol; 1995 Sep; 36(5):520-8. PubMed ID: 7640098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
    Aprile I; Muti M; Principi M; Bartolini N; Zenoni A; Tazza G; Italiani M; Ottaviano P
    Radiol Med; 2002; 104(1-2):87-91. PubMed ID: 12386559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
    Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.